Guidelines for breast and ovarian cancer genetic counseling referral: Adoption and implementation in HMOs

Genetics in Medicine

Volumn 5, Issue 6, 2003, Pages 444-450

  Mouchawar, Judy ^a   Goins, Karin Valentine ^b   Somkin, Carol ^a   Puleo, Elaine ^c   Alford, Sharon Hensley ^d   Geiger, Ann M ^a   Taplin, Stephen ^e   Gilbert, Joyce ^a   Weinmann, Sheila ^a   Zapka, Jane ^b  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

^d HENRY FORD HEALTH SYSTEM   (United States)

^e CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Breast Cancer; Guidelines; Hereditary; Managed care

Indexed keywords

ARTICLE; AWARENESS; BREAST CANCER; CLINICAL PRACTICE; FEMALE; GENETIC COUNSELING; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH MAINTENANCE ORGANIZATION; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; MALE; ONSET AGE; OVARY CANCER; PATIENT REFERRAL; PRACTICE GUIDELINE;

BREAST NEOPLASMS; FEMALE; GENETIC COUNSELING; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; LOGISTIC MODELS; OVARIAN NEOPLASMS; PRACTICE GUIDELINES; REFERRAL AND CONSULTATION;

EID: 10744231817     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GIM.0000093979.08524.86     Document Type: Article

References (29)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:120-122.
2. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;285:2088-2090.
3. Statement of the American Society of Hum Genet on genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet 1994;55:i-iv. Available at: http://www.ash.org/genetics/ashg/pubs/policy/pol-11.htm Accessed September 30, 2003.
4. Committee on genetics. ACOG committee opinion breast-ovarian cancer screening. Int J Gynecol Obstetrics 1997;56:82-83.
5. American Medical Association. Identifying and managing hereditary risk for breast and ovarian cancer. 2003. Available at: http://www.ama-assn.org/ama/pub/category/10183.html Accessed September 30, 2003.
6. Statement of the American Society of Clinical Oncology. Genetic testing for cancer susceptibility. J Clin Oncol. 1996;14:1730-1736.
7. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE et al. Assessment and counseling for women with a family history of breast cancer: A guide for clinicians. JAMA 1995;273:577-585.
8. American College of Medical Genetics Professional Practice, and Guidelines Committee. Genetic susceptibility to breast and ovarian cancer: Assessment, counseling, and testing guidelines executive summary. 1999:1-36. Available at: http://www.health.state.ny.us. Accessed September 30, 2003.
9. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G et al. BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. JAMA 1996;275:1885-1892.
10. Lerman C, Croyle R. Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med 1994;154:609-616.
11. Lodder L, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Duivenvoorden HJ et al. Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet 2001;98:15-24.
12. Meiser B, Butow PN, Barratt AL, Schnieden V, Gattas M, Kirk J et al. Psychological Impact Collaborative Group. Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer. Patient Educ Couns 2001;44:215-225.
13. Cummings S, Olopade O. Predisposition testing for inherited breast cancer. Oncology 1998;12:1227-1241.
14. Mouchawar J, Klein C, Mullineaux L. Colorado physicians' hereditary breast cancer knowledge and practice behavior. J Cancer Educ 2001;16:33-37.
15. National Institutes of Health National Cancer Institute Applied Research Program. National physician survey on genetic testing for inherited cancer susceptibility. Presented at 5th International Symposium on Preventive Oncology and Therapy. Geneva; October 2000.
16. Acton RT, Burst NM, Casebeer L, Ferguson SM, Greene P, Laird BL et al. Knowledge, attitude, and behaviors of Alabama's primary care physicians regarding cancer genetics. Acad Med 2000;75:850-852.
17. Escher M, Sappino AP. Primary care physician's knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann Oncol 2000 Sep;11:1131-1135.
18. Kutner SE. Breast cancer genetics and managed care: The Kaiser Permanente experience. Cancer 1999;86(suppl 11):2570-2574.
19. Myers MF, Doksum T, Holtzman NA. Genetic services for common complex disorders: Surveys of health maintenance organizations and academic genetic centers. Genet Med 1999;1:272-285.
20. Goins KV, Zapka J, Geiger A, Solberg L, Mouchawar J, Gilbert J, Ulcickas-Yood M, Taplin S. Implementation of systems strategies for breast and cervical cancer screening services in Health Maintenance Organizations. Am J Manag Care In press.
21. Puleo E, Zapka J, White M, Mouchawar J, Somkin C, Taplin S. Caffeine, cajoling and other strategies to maximize clinician survey response rates. Eval Health Prof 2002;25:169-184.
22. Malone KE, Daling JR, Thompson JD, O'Brien CA, Francisco LV, Ostrander EA. BRCA1 mutations and breast cancer in the general population: Analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA 1998;279:922-929.
23. Isaacs C, Peshkin BN, Schwartz M, Demarco TA, Main D, Lerman C. Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Res Treat 2002;71:103-112.
24. Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 2002;20:1260-1268.
25. Velicer CM, Taplin S. Genetic testing for breast cancer: Where are health care providers in the decision process? Genet Med 2001;3:112-119.
26. Tessaro I, Borstelmann N, Regan K, Rimer BK, Winer E. Genetic testing for susceptibility to breast cancer: Findings from women's focus groups. J Womens Health 1997;6:317-327.
27. Davis DA, Thomson MA, Oxman AD, Haynes B. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995 274:700-705.
28. Davis D, Thomson O'Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education: Do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA 1999 282:867-874.
29. Tu K, Davis D. Can we alter physician behavior by educational methods? Lessons learned from studies of the management and follow-up of hypertension. J Cont Med Ed Health Prof 2002 22:11-22.